Results 21 to 30 of about 1,722,968 (253)

The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL)

open access: yesCells, 2022
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia among adults. It is the clonal expansion of B cells expressing CD19 and CD5. Despite significant progress in treatment, CLL is still incurable.
Michał K. Zarobkiewicz   +1 more
doaj   +1 more source

Disease-specific complications of chronic lymphocytic leukemia in binet stage a patients [PDF]

open access: yes, 2012
Disease-specific Complications of Chronic Lymphocytic Leukemia in Binet Stage A Patients: Analysis of Immunodeficiency, Autoimmune Constellations and Infections in the CLL1-Protocol.
Kwag, Doo Young
core   +1 more source

Regularities of cytokine status changes in chronic lymphocytic leukaemia and their role in pathogenesis of progressive forms of disease [PDF]

open access: yesСаратовский научно-медицинский журнал, 2012
The aim of the research is to study and to analyze results of investigations of cytokine blood profile in patients with B-cellular chronic lymphocytic leukaemia.
Shelekhova T.V.   +2 more
doaj  

Living with chronic lymphocytic leukaemia: patient perspectives from a global online cross-sectional survey on care pathways and impacts on quality of life

open access: yesFrontiers in Hematology
BackgroundChronic Lymphocytic Leukaemia (CLL) is a slow-progressing condition often managed through active monitoring (“watch and wait”) strategies, which can lead to uncertainty for patients about prognosis, symptom management, and immunity-related ...
Kathryn Huntley   +6 more
doaj   +1 more source

Prognostic factors for survival in patiens with chronic lymphocytic leukemia [PDF]

open access: yes, 2012
The purpose of this study is to analyse the quality of the prognostic factors to prognose the survival time and progression for patients with chronic lymphocytic leukemia (CLL) in early stage.
Wijaya, Ferry
core   +1 more source

PLCG2 exon-skipped variants: insights into their potential role in chronic lymphocytic leukemia

open access: yesBlood Advances
: Bruton tyrosine kinase inhibitors (BTKi) are successful in the treatment of chronic lymphocytic leukemia (CLL), yet acquired resistance remains a challenge.
Jialei Qi   +18 more
doaj   +1 more source

The Occurrence of Richter’s Syndrome during Treatment with Obinutuzumab and Chlorambucil

open access: yesCase Reports in Hematology, 2020
Chronic lymphocytic leukaemia is a slow-growing leukaemia of developing B-lymphocytes, which may transform to an aggressive lymphoma known as Richter’s syndrome. While Richter’s syndrome can present in untreated or relapsed-refractory cases, it may occur
Teng Fong Ng   +4 more
doaj   +1 more source

Chronic lymphocytic leukaemia (CLL) [PDF]

open access: yes, 2005
Review on Chronic lymphocytic leukaemia (CLL), with data on clinics, and the genes ...
Reddy, KS
core   +1 more source

p53 expression in chronic lymphocytic leukaemia

open access: yesمجلة كلية الطب, 2005
Background:
Nasir AL-Allawi   +4 more
doaj   +1 more source

Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study

open access: yesFrontiers in Hematology
BackgroundDisease-specific factors associated with decreased quality of life (QoL) in patients with leukemia have not been studied in a large-scale, global, observational study.MethodsThis cross-sectional study used the validated Hematological Malignancy
Sam Salek   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy